Equibles does not estimate personal net worth.
Get an email with a short summary when Agios Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get AGIO alertsJacqualyn Fouse is recorded as CEO and Board Member at Agios Pharmaceuticals, Inc. (AGIO). The proxy statement of Agios Pharmaceuticals, Inc. reports total compensation of $4,911,049 for Jacqualyn Fouse in fiscal 2022, including a base salary of $466,761. Disclosed compensation is on record for 6 fiscal years. Jacqualyn Fouse has spoken on 4 earnings calls across 1 company, most recently for Agios Pharmaceuticals, Inc. on July 29, 2021. Agios Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Agios Pharmaceuticals, Inc. includes Brian Goff (CEO and Board Member), David P. Schenkein (Chairman), Jacqualyn A. Fouse (Chairman) and 7 others.
“Good morning, everyone, and thanks for joining our second quarter 2021 financial results call. We are pleased to report another quarter of strong progress at Agios, the first full quarter since the close of the sale of our oncology business to Servier.”
“The first three months of this year were extremely productive. We closed the sale of our Oncology business, accelerated our late-stage clinical programs for mitapivat and prepared for our first regulatory filings and subsequent commercial launch in pyruvate kinase deficiency.”
“The second quarter was an incredibly productive and important time for Agios as we made significant progress across the business and accomplished several of the key objectives that we set for 2020.”
“At the beginning of the year we laid out ambitious plans for 2020. Along with the rest of the world, we couldn’t know what challenges would lie ahead related to the impact of the COVID-19 pandemic.”
Proxy statement
Biotechnology · Healthcare
CEO, Board Member
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Agios Pharmaceuticals, Inc. (AGIO) | Former Chief Executive Officer | $466,761 | $4,911,049 |
| 2021 | Agios Pharmaceuticals, Inc. (AGIO) | Former Chief Executive Officer | $760,000 | $6,519,427 |
| 2020 | Agios Pharmaceuticals, Inc. (AGIO) | Former Chief Executive Officer | $746,750 | $7,611,975 |
| 2019 | Agios Pharmaceuticals, Inc. (AGIO) | Chief Executive Officer | $664,583 | $16,607,994 |
| 2018 | Agios Pharmaceuticals, Inc. (AGIO) | Chief Executive Officer | — | — |
| 2017 | Agios Pharmaceuticals, Inc. (AGIO) | Chief Executive Officer | — | — |
